Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

NCT01703234 is registered in ClinicalTrials.gov with Gulhane School of Medicine as lead sponsor.

NCT NCT01703234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01703234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients
Lead sponsor
Gulhane School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
April 30, 2009
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, diabetic nephropathy, proteinuria